Flagship Wealth Advisors’s GSK GSK Stock Holding History

Flagship Wealth Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$43.1K	Sell	1,122 -10	-0.9%	-$542	0.02%	201
2025 Q4	$55.5K	Buy	1,132 +5	+0.4%	+$233	0.02%	210
2025 Q3	$48.7K	Buy	1,127 +5	+0.4%	+$195	0.02%	221
2025 Q2	$43.1K	Buy	1,122 +5	+0.4%	+$191	0.02%	218
2025 Q1	$43.3K	Buy	1,117 +5	+0.4%	+$183	0.02%	213
2024 Q4	$37.6K	Buy	+1,112	New	+$40K	0.02%	208

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Flagship Wealth Advisors's GSK Position: Q1 2026 in Review

Flagship Wealth Advisors reduced its GSK (GSK) stake by 0.88% in Q1 2026, selling an estimated $542 and leaving 1,122 shares worth $43.1K. The position accounts for 0.02% of the portfolio, ranked #201.

Flagship Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 6 quarters since. The position peaked at $55.5K in Q4 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Flagship Wealth Advisors held 1,122 shares of GSK worth $43.1K as of Q1 2026.
Flagship Wealth Advisors sold 10 GSK shares in Q1 2026, an estimated $542.
GSK made up 0.02% of Flagship Wealth Advisors's portfolio in Q1 2026, its #201 holding.
Flagship Wealth Advisors first reported a position in GSK in Q4 2024 and has held it in 6 quarters since.
Flagship Wealth Advisors's GSK position peaked at $55.5K in Q4 2025.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Flagship Wealth Advisors's 13F filing for Q1 2026, filed 1 Jun 2026.